References
- 1. Ayuk J, Sheppard MC. Growth hormone and its disorders. Postgrad Med J. 2006; 82:24-30.10.1136/pgmj.2005.036087
- 2. Choi HK, Waxman DJ. Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action. Growth Horm IGF Res. 2000; 10 (Suppl B):S1-S8.
- 3. Giannoulis MG, Jackson N, Shojaee-Moradie F, Nair KS, Sonksen PH, Martin FC, et al. The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2008; 93:3066-74.10.1210/jc.2007-2695
- 4. Harridge SD, Velloso CP. Gene doping. Essays Biochem. 2008; 44:125-38.10.1042/bse04400125
- 5. Rosenbloom AL. Insulin-like growth factor-I (rhIGF-I) therapy of short stature. J Pediatr Endocrinol Metab. 2008; 21:301-15.
- 6. Hepner F, Cszasar E, Roitinger E, Lubec G. Mass spectrometrical analysis of recombinant human growth hormone (Genotropin®) reveals amino acid substitutions in 2% of the expressed protein. Proteome Sci (on line). 2005 [cited 2005 Feb 13]. Available from: <http://www.proteomesci.com/content/3/1/1>
- 7. Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli F, Wilson JM, et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA. 1999; 96:8657-62.10.1073/pnas.96.15.8657
- 8. Büning H, Perabo L, Coutelle O, Quadt-Humme S, Hallek M. Recent developments in adeno-associated virus vector technology. Gene Med. 2008; 10:532 717-33.
- 9. Donsante A, Vogler C, Muzyczka N, Crawford JM, Barker J, Flotte T, et al. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther. 2001; 8:1343-6.10.1038/sj.gt.3301541
- 10. Qin Y, Tian YP. Microarray gene analysis of peripheral whole blood in normal adult male rats after chronic GH gene therapy. Cell Mol Biol Lett. 2010; 15:177-95.
- 11. Qin Y, Tian YP. Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Mol Med Rep. 2010; 3:525-30.10.3892/mmr_00000292
- 12. Yan H, Guo Y, Zhang P, Zu L, Dong X, Chen L, et al. Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. Biochem Biophys Res Commun. 2005; 336:278-87.
- 13. Snyder R, Xiao X, Samulski RJ. Production of recombinant adenoassociated viral vectors. In: Smith D eds. Current Protocols in Human Genetics. New York: Wiley; 1996. p. 12.1.1-2.23.
- 14. Sasaki TM, Sonnae A. Effect of acetic acid concentration on the color reaction in the otoluidineboric acid method for blood glucose estimation (in Japanese). Rinsho Kagaku. 1972;1:346-53.
- 15. Iglesias P, D_ez JJ. Clinical applications of recombinant human growth hormone in adults. Expet Opin Pharmacother. 1999; 1:97-107
- 16. Marmary Y, Parlow AF, Goldsmith CM, He X, Wellner RB, Satomura K, et al. Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone. Endocrinology. 1999; 140:260-5.
- 17. Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli F, Wilson JM, et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA. 1999; 96:8657-62.10.1073/pnas.96.15.8657
- 18. Zhang N, Clement N, Chen D, Fu S, Zhang H, Rebollo P, et al. Transduction of pancreatic islets with pseudotyped adeno-associated virus: effect of viral capsid and genome conversion. Transplantation. 2005; 80:683-90.10.1097/01.tp.0000173381.97556.0d
- 19. Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest. 2004; 113:25-7.
- 20. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K. Changes in serum insulin-like growth factor I (IGF-I) and IGF-Binding Protein-3 levels during growth hormone treatment in prepubertal short children born small for 527 gestational age. J Clin Endocrinol Metab. 1996; 81:3902-8.